MIF/NR3C2 Axis Regulates Glucose Metabolism Reprogramming in Pancreatic Cancer Through MAPK-ERK and AP-1 Pathways Get Access Arrow

Scientists provided evidence that migration inhibitory factor (MIF) and nuclear receptor subfamily 3 group C member 2 (NR3C2) interactively regulated metabolic reprogramming, resulting in MIF-induced cancer growth and progression in PDAC.